The following article was featured in:
Source:
Your Health Matters
06/12/2025.
The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial virus, or RSV, a common but potentially serious seasonal illness.
The drug,...
Continue on to full article...
